What it is · 20-person evidence · product checks
Elravie RE2O
What the published study tested — and what it did not
Board-Certified
Dermatologist
AAD International Fellow
IFAAD
- Duration
- Set after assessment
- Sessions
- No universal course
- Downtime
- Varies by plan
Elravie RE2O in Seoul
Elravie RE2O (also written 'Elravie RE20') is the L&C Bio product identified in a 2026 study of injectable particulated human acellular dermal matrix (phADM), a donor-dermis material processed to remove cells. The trial enrolled 20 adults with moderate cheek roughness and compared phADM mixed with hyaluronic acid against hyaluronic acid on the opposite cheek for 20 weeks; it did not test RE2O alone. A preliminary study of that size cannot establish a universal course, long-term durability, or suitability for every concern. This page does not confirm clinic stock or Korean product status.
- Evidence
- One 2026 split-face study
- Participants
- 20 adults
- Study length
- 20 weeks
- What was compared
- phADM mixed with HA, against HA alone
Elravie RE2O
The identity of the product in the syringe is the part you can check yourself, and it is worth checking.
What the material is
Particulated human acellular dermal matrix — donor dermis processed to remove cells. It is a different class of material from hyaluronic acid, polynucleotide or PDLLA products, and evidence does not transfer between them.
What the study actually used
The clinical side received phADM mixed with hyaluronic acid, while the opposite cheek received hyaluronic acid alone. The paper therefore does not isolate what RE2O does on its own, and a clinic protocol must not be inferred from it.
Check the packaging before you consent
Ask to see sealed packaging and read it yourself: the exact names Elravie RE2O and L&C Bio, the lot number, and the expiry date. This is a reasonable request and a clinic that will not show you is telling you something.
Documentation to request
The applicable Korean product and tissue-traceability documentation, plus an itemized written quote once the plan is defined. Defer if identity, documentation, availability or aftercare cannot be confirmed.
What this page does not tell you
No verified clinic price or current availability is stated here, and this page does not confirm clinic stock or Korean product status. Confirm both in writing before traveling.
How the Decision Is Made
01Define the concern
A dermatologist establishes what is actually bothering you and whether it resembles the population in the cited trial — 20 adults whose main concern was moderate cheek roughness.
02Compare alternatives honestly
phADM is weighed against hyaluronic acid and other options without transferring outcomes between them. Twenty participants over 20 weeks cannot define uncommon or long-term harms, and that limit is stated rather than glossed.
03Verify the exact product
Before consent, inspect the sealed packaging for the Elravie RE2O and L&C Bio names, lot number and expiry, and request the applicable product and tissue-traceability documentation with an itemized written quote.
04Decide, or defer
Individual risks and recovery needs are reviewed. The paper reported transient redness and slight swelling that resolved without treatment, but gave no dependable recovery duration and no rule for makeup, cleansing, exercise, heat or flying — so obtain written aftercare before fixing travel or event dates.
Frequently Asked Questions
Q.What is Elravie RE2O?
The cited paper identifies Elravie RE2O from L&C Bio as particulated human acellular dermal matrix made from processed donor dermis. Its clinical test side received phADM mixed with HA, while the opposite cheek received HA; the study therefore does not isolate the effect of RE2O alone.
Q.Who may consider RE2O, and what are the evidence limits?
The closest published population was 20 adults with moderate cheek roughness. That may inform a consultation, but it is not a general eligibility rule. The small, 20-week study cannot establish a universal course, guaranteed outcome, rare-event safety, or long-term durability.
Q.How much downtime should I plan before travel?
The study reported transient redness and slight swelling that resolved without treatment, but it did not state a dependable recovery duration or rules for makeup, cleansing, exercise, heat, or flights. Do not plan around a fixed recovery promise; obtain individualized written aftercare first.
Q.What does RE2O cost, and how can I verify the exact product?
No verified clinic price or current availability is stated on this page. Request an itemized written quote only after the plan is defined. Before consent, inspect sealed packaging for Elravie RE2O, L&C Bio, the lot number, and expiry, and request the applicable Korean product and tissue-traceability documents. Defer if those details cannot be confirmed.
References2
The clinical claims on this page — device specs, efficacy timelines, safety profile — are supported by the primary sources below. Each citation links to the original paper or regulatory record.
- [1]Injectable Particulated Human Acellular Dermal Matrix Booster for Skin Restoration. Int J Mol Sci — randomized split-face trial, 20 adults, 20-week follow-up; preliminary evidence (2026).
- [2]ClinicalTrials.gov Study Record NCT07155278. ClinicalTrials.gov — registered split-face design and follow-up; not a clinic protocol (2025).
Session summary & comparison
| Item | Details |
|---|---|
| Product identity | The cited paper identifies L&C Bio Elravie RE2O as donor-derived particulated human acellular dermal matrix (phADM) |
| What was studied | A split-face study in 20 adults with moderate cheek roughness compared phADM mixed with hyaluronic acid against hyaluronic acid for 20 weeks |
| What was not established | The study did not isolate RE2O alone and cannot establish a universal course, rare-event safety, or long-term durability |
| Recovery and travel | The study does not provide a dependable recovery window; request individualized written aftercare before planning travel |
| Product and price check | Confirm sealed packaging, manufacturer, lot, expiry, applicable documentation, and an itemized written quote before consent |
Related procedures
Evidence & comparison guides
Need another answer before deciding?
You do not need to read every guide. Open the question that still matters to your decision.
Notice: Individual results may vary depending on skin condition, treatment history, and recovery factors. All treatment plans are determined through individual consultation with a board-certified dermatologist. The information on this page is for reference only and does not constitute medical advice or guarantee specific outcomes.
Next Step